Board Meeting22 Jul 2026, 03:31 pm
Oxygenta Pharmaceutical Board Meeting on July 25, 2026
AI Summary
Oxygenta Pharmaceutical Ltd has announced that its Board of Directors will convene on Saturday, July 25, 2026. The primary agenda items include the consideration and approval of the un-audited financial results for the quarter ended June 30, 2026, along with the associated Limited Review Report. The meeting will also address any other business as permitted by the Chair. This notification is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for July 25, 2026.
- To consider un-audited financial results for Q1 FY27.
- Limited Review Report for the quarter will be discussed.
- Compliance with SEBI LODR Regulations, 2015.
Price Impact
More from OXYGENTAPH